GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Adcock Ingram Holdings Ltd (JSE:AIP) » Definitions » Capex-to-Revenue

Adcock Ingram Holdings (JSE:AIP) Capex-to-Revenue : 0.01 (As of Jun. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Adcock Ingram Holdings Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Adcock Ingram Holdings's Capital Expenditure for the six months ended in Jun. 2024 was R-54.80 Mil. Its Revenue for the six months ended in Jun. 2024 was R4,902.70 Mil.

Hence, Adcock Ingram Holdings's Capex-to-Revenue for the six months ended in Jun. 2024 was 0.01.


Adcock Ingram Holdings Capex-to-Revenue Historical Data

The historical data trend for Adcock Ingram Holdings's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adcock Ingram Holdings Capex-to-Revenue Chart

Adcock Ingram Holdings Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Capex-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.02 0.03 0.04 0.02 0.01

Adcock Ingram Holdings Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.01 0.02 0.02 0.01

Competitive Comparison of Adcock Ingram Holdings's Capex-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Adcock Ingram Holdings's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Adcock Ingram Holdings's Capex-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Adcock Ingram Holdings's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Adcock Ingram Holdings's Capex-to-Revenue falls into.



Adcock Ingram Holdings Capex-to-Revenue Calculation

Adcock Ingram Holdings's Capex-to-Revenue for the fiscal year that ended in Jun. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-127.741) / 9643.128
=0.01

Adcock Ingram Holdings's Capex-to-Revenue for the quarter that ended in Jun. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-54.8) / 4902.704
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Adcock Ingram Holdings  (JSE:AIP) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Adcock Ingram Holdings Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Adcock Ingram Holdings's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Adcock Ingram Holdings Business Description

Traded in Other Exchanges
N/A
Address
1 New Road, (c/o New Road & 7th Street), Midrand, Johannesburg, GT, ZAF, 1682
Adcock Ingram Holdings Ltd is a drug manufacturing company. The company manufactures, markets, and distributes a wide range of healthcare products. The company's reportable segment include Consumer, OTC, Prescription, Hospital and Other-shared services, out of which it generates maximum revenue from Prescription segment. Geographically it operates in Southern Africa and India.